Epidermal growth factor receptor activation and inhibition in 3Din vitromodels of normal skin and human cutaneous squamous cell carcinoma

Is the Ki-67 labelling index ready for clinical use?

(2011) W. Jonat et al.   ANNALS OF ONCOLOGY

Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: Molecular bases for EGFR-targeted therapy

(2011) Pablo Uribe et al.   PATHOLOGY RESEARCH AND PRACTICE

Epidermal growth factor receptor gene numerical aberrations are frequent events in actinic keratoses and invasive cutaneous squamous cell carcinomas

(2010) Agustí Toll et al.   EXPERIMENTAL DERMATOLOGY

Evidence-Based Treatment Options for the Management of Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors

(2009) Eng Hooi Tan et al.   ANNALS OF PHARMACOTHERAPY

Erlotinib-Induced Skin Rash in Patients with Non–Small-Cell Lung Cancer: Pathogenesis, Clinical Significance, and Management

(2009) Sotirios Tsimboukis et al.   Clinical Lung Cancer

Anin vitrothree-dimensional model of primary human cutaneous squamous cell carcinoma

(2009) Suzan Commandeur et al.   EXPERIMENTAL DERMATOLOGY

Skin toxicities associated with epidermal growth factor receptor inhibitors

(2009) Tianhong Li et al.   Targeted Oncology